Paper337363
The utility of protected-environment regimens for the compromised host: a critical assessment.
Pizzo PA and 1 other. Prog Hematol, 1977. Cited by 15 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The utility of protected-environment regimens for the compromised host: a critical assessment. Papers, record 337363. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/337363
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The utility of protected-environment regimens for the compromised host: a critical assessment.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Infections | Major topic |
| Environment, Controlled | Major topic |
| Neoplasms | Major topic |
| Acute Disease | |
| Anemia, Aplastic | |
| Antibiotics, Antineoplastic | |
| Filtration | |
| Hospital Design and Construction | |
| Humans | |
| Immunologic Deficiency Syndromes | |
| Leukemia | |
| Lymphoma |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8,739,653 | Prevention of infection in children with acute leukaemia. No major difference between total and selective bowel decontamination. | Support Care Cancer | 1996 | https://conductscience.org/library/papers/8739653 | PubMed |
| 7,726,614 | A survey of recommendations given to patients going home after bone marrow transplant. | Arch Dis Child | 1994 | https://conductscience.org/library/papers/7726614 | PubMed |
| 6,928,791 | The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia. | Blut | 1980 | https://conductscience.org/library/papers/6928791 | PubMed |
| 6,880,186 | Preventing infection in neutropenic cancer patients. | West J Med | 1983 | https://conductscience.org/library/papers/6880186 | PubMed |
| 6,772,872 | [Hematopoietic stimulation for enhanced bone marrow regeneration after chemotherapy (author's transl)]. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/6772872 | PubMed |
| 6,769,945 | Simple and microbiologically safe portable transport unit for patients requiring protected isolation. | J Clin Microbiol | 1980 | https://conductscience.org/library/papers/6769945 | PubMed |
| 98,107 | Infection in acute leukemia patients receiving oral nonabsorable antibiotics. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/98107 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/337363
GET https://conductscience.org/api/papers/v1/337363/authors